Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals

The use of COVID-19 vaccines will play the major role in helping to end the pandemic that has killed millions worldwide. COVID-19 vaccines have resulted in robust humoral responses and protective efficacy in human trials, but efficacy trials excluded individuals with a prior diagnosis of COVID-19. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Samanovic, Marie I., Cornelius, Amber R., Gray-Gaillard, Sophie L., Allen, Joseph Richard, Karmacharya, Trishala, Wilson, Jimmy P., Hyman, Sara Wesley, Tuen, Michael, Koralov, Sergei B., Mulligan, Mark J., Herati, Ramin Sedaghat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885942/
https://www.ncbi.nlm.nih.gov/pubmed/33594383
http://dx.doi.org/10.1101/2021.02.07.21251311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885942/
https://www.ncbi.nlm.nih.gov/pubmed/33594383
http://dx.doi.org/10.1101/2021.02.07.21251311

Ejemplares similares